Page last updated: 2024-09-05

deferasirox and Chronic Kidney Diseases

deferasirox has been researched along with Chronic Kidney Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Díaz-García, JD; Gallegos-Villalobos, A; Gonzalez-Espinoza, L; Ortiz, A; Sanchez-Niño, MD; Villarrubia, J1
Chen, CH; Shu, KH; Yang, Y1
Eguchi, A; Fujii, A; Hirotani, S; Iwasaku, T; Masuyama, T; Morisawa, D; Naito, Y; Oboshi, M; Okuhara, Y; Sawada, H1
Batty, KT; Ferrari, P; Maker, GL; Olynyk, JK; Siva, B; Trengove, RD1

Reviews

1 review(s) available for deferasirox and Chronic Kidney Diseases

ArticleYear
Deferasirox nephrotoxicity-the knowns and unknowns.
    Nature reviews. Nephrology, 2014, Volume: 10, Issue:10

    Topics: Acute Kidney Injury; Benzoates; Deferasirox; Glomerular Filtration Rate; Humans; Iron Chelating Agents; Iron Overload; Renal Insufficiency, Chronic; Transfusion Reaction; Triazoles

2014

Trials

1 trial(s) available for deferasirox and Chronic Kidney Diseases

ArticleYear
Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis.
    Nephrology (Carlton, Vic.), 2013, Volume: 18, Issue:3

    Topics: Aged; Anemia, Iron-Deficiency; Area Under Curve; Benzoates; Biological Availability; Chromatography, Liquid; Deferasirox; Drug Administration Schedule; Drug Monitoring; Female; Hematinics; Humans; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Pilot Projects; Renal Dialysis; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Triazoles; Western Australia

2013

Other Studies

2 other study(ies) available for deferasirox and Chronic Kidney Diseases

ArticleYear
Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload.
    Hematology (Amsterdam, Netherlands), 2015, Volume: 20, Issue:5

    Topics: Administration, Oral; Adult; Aged; Anemia; Benzoates; Chelation Therapy; Deferasirox; Female; Hematopoiesis; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Transfusion Reaction; Treatment Outcome; Triazoles

2015
Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2015, Volume: 38, Issue:7

    Topics: Animals; Benzoates; Blood Pressure; Deferasirox; Fibrosis; Gene Expression; Iron; Iron Chelating Agents; Kidney; Male; Nephrectomy; Nephritis, Interstitial; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Triazoles

2015